Cytopathology foundation thanks all 2012 and 2013 CytoJournal *peer reviewers* for extending their resources by devoting significant efforts and time. Contribution of high quality scientific cytopathology literature through public domain under open access (OA) charter of CytoJournal is only possible with continued dedication of this segment of academia.

CytoJournal *peer reviewers* are critical for its continued contribution of scientific cytopathology literature to the public domain under its open access (OA) charter. CytoJournal editorial board and cytopathology foundation (CF) thank all CytoJournal *peer reviewers* for their devotion by extending their significant efforts, time, and resources by completing the review process of all cytojournal manuscripts in a timely manner published during 2012 \[[Table 1](#T1){ref-type="table"}\]\[[@ref1][@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24]\] and 2013 \[[Table 2](#T2){ref-type="table"}\].\[[@ref25][@ref26][@ref27][@ref28][@ref29][@ref30][@ref31][@ref32][@ref33][@ref34][@ref35][@ref36][@ref37][@ref38][@ref39][@ref40][@ref41][@ref42][@ref43][@ref44][@ref45][@ref46][@ref47][@ref48][@ref49]\] The overall acceptance rate was 52% during 2012 and 54% during 2013. Hence, there were many more manuscripts, which were reviewed but recommended for non-acceptance. Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} include all the reviewers participating in the *peer-review* process for all the manuscripts during this period. The reviewers for individual manuscripts are assigned from the CytoJournal *core reviewer panel*. The list of all the CytoJournal *core reviewer panel* members is updated periodically on CytoJournal home page.\[[@ref50]\]
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We thank all the authors for their continued support by publishing with CytoJournal which provides a robust OA platform. Global dissemination of their high-value cytopathology and related scientific literature as a freely available resource all over the world without losing their hard-earned copyright has been increasingly relevant. OA charter allows all CytoJournal authors to share their copyrights in the public domain under the terms of the creative commons attribution license.\[[@ref51]\] In addition to general public benefits with barrier free, global access to a high standard scientific cytopathology knowledge, the authors as academia enjoy wider global dissemination of their work under OA charter. This translates into higher visibility with increased downloads and impact.\[[@ref52][@ref53][@ref54]\] Although actual quality and novelty of the individual study articles are the most critical factors, the probabilities of citation with continuous referencing is facilitated with increasing ease by the web matrix. If we apply Moore\'s law to this phenomenon of OA on the web, it suggests an increasingly higher impact with a tremendous long-term rewards.\[[@ref55][@ref56]\]

Finally, we thank all the CytoJournal authors, readers, and supporting academia for considering CytoJournal as their OA platform for cytopathology, scientific, *peer-reviewed* information around the globe. Our best wishes to all CytoJournal editorial board members, reviewers, authors, and readers for ongoing, collective academic prosperity.
